LNSR
LENSAR, Inc.Company Information
- Company Name
- LENSAR, Inc.
- CIK
- CIK0001320350
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- LNSR: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- LNSR
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-09-03
- Last sale
- —
- Shares purchased (TTM)
- 5,487
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 4,406,637
- Shares outstanding
- 12,297,000
- Ownership
- 35.84%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 3.75%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 14 | 12 | 13 | 8 | 7 | 20 | 16 | 10 | 8 | 14 | 21 | 25 | ||||||
| Short Term Investments | 0 | 1 | 5 | 9 | 13 | 6 | 6 | 8 | 6 | 4 | 3 | - | ||||||
| Accounts Receivable Net Current | 6 | 5 | 6 | 6 | 5 | 7 | 6 | 4 | 6 | 4 | 4 | 4 | ||||||
| Notes And Loans Receivable Net Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 25 | 23 | 22 | 21 | 19 | 15 | 11 | 15 | 18 | 18 | 16 | 17 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Assets Current | 47 | 42 | 47 | 44 | 46 | 49 | 42 | 39 | 40 | 42 | 46 | 49 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Long Term Investments | - | - | - | - | - | - | - | 0 | 1 | 1 | 0 | - | ||||||
| Notes And Loans Receivable Net Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Finite Lived Intangible Assets Net | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 | 11 | 11 | 11 | ||||||
| Other Assets Noncurrent | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | ||||||
| Assets | 70 | 66 | 71 | 70 | 70 | 73 | 66 | 62 | 61 | 66 | 70 | 71 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 11 | 10 | 19 | 15 | 11 | 8 | 6 | 4 | 4 | 4 | 4 | 4 | ||||||
| Accrued Liabilities Current | 5 | 4 | 8 | 8 | 6 | 7 | 7 | 6 | 4 | 4 | 6 | 5 | ||||||
| Contract With Customer Liability Current | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Liabilities Current | 20 | 18 | 41 | 36 | 30 | 27 | 15 | 12 | 10 | 10 | 12 | 11 | ||||||
| Long Term Notes Payable | 4 | 5 | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | ||||||
| Liabilities | 41 | 42 | 84 | 82 | 80 | 81 | 48 | 25 | 24 | 21 | 22 | 21 | ||||||
| Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 152 | 152 | 151 | 150 | 149 | 148 | 148 | 147 | 147 | 146 | 145 | 144 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | 0 | - | ||||||
| Retained Earnings Accumulated Deficit | -138 | -141 | -178 | -176 | -172 | -171 | -143 | -125 | -123 | -114 | -112 | -108 | ||||||
| Stockholders Equity | 15 | 11 | -26 | -26 | -23 | -22 | 5 | 23 | 24 | 32 | 33 | 36 | ||||||
| Liabilities And Stockholders Equity | 70 | 66 | 71 | 70 | 70 | 73 | 66 | 62 | 61 | 66 | 70 | 71 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Allowance For Notes And Loans Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Allowance For Notes And Loans Receivable Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Temporary Equity Shares Authorized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Temporary Equity Liquidation Preference | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | ||||||
| Shares Outstanding | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 11 | 11 | 11 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialLENSAR, Inc. (LNSR) — SEC Financial Statements & Analysis
LENSAR, Inc. (LNSR) is a surgical & medical instruments & apparatus company, incorporated in DE. LENSAR, Inc. trades on Nasdaq as: LNSR. LENSAR, Inc. (LNSR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, LENSAR, Inc. carries a market cap of $70.22M, a P/E ratio of 2.02x, a P/B ratio of 4.71x, a P/S ratio of 1.20x, an enterprise value of $60.40M, and an EV/EBITDA multiple of -13.33x. On profitability, it posts a gross margin of 46.96%, an operating margin of -13.84%, a net margin of 59.11%, a Return on Equity (ROE) of -851.75%, a Return on Assets (ROA) of 49.58%, and a Return on Invested Capital (ROIC) of -96.63%. Per share, it reports EPS of $2.82, diluted EPS of $1.51, free cash flow per share of $-0.60, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 15.33% year-over-year, net income growth of -170.36% year-over-year, and EPS growth of -168.30% year-over-year. On the balance sheet, it maintains a current ratio of 2.39x, a quick ratio of 1.03x, working capital of $27.39M, a debt-to-equity ratio of 2.74x, a debt ratio of 0.59, free cash flow of $-7.33M (TTM), and net debt of $-9.81M. Figures sourced from SEC EDGAR.
- Market Cap
- $70.22M
- P/E TTM
- 2.02x
- EPS TTM
- $2.82
- P/B TTM
- 4.71x
- ROE TTM
- -851.75%
- ROA TTM
- 49.58%
- Debt To Equity
- 2.74x
- Free Cash Flow TTM
- $-7.33M
- Net Revenue TTM Growth 1Y
- 15.33%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LENSAR, Inc. in?
LENSAR, Inc. (LNSR) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does LNSR trade on?
LENSAR, Inc. (LNSR) trades on the Nasdaq.
Where is LENSAR, Inc. incorporated?
LENSAR, Inc. is incorporated in DE.
When was LENSAR, Inc. (LNSR)'s most recent SEC filing?
LENSAR, Inc. (LNSR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is LNSR's market cap?
LENSAR, Inc. (LNSR) has a market capitalization of $70.22M as of 2026-06-30.
What is LNSR's P/E ratio?
LENSAR, Inc. (LNSR)'s trailing twelve month P/E ratio is 2.02x as of 2026-06-30.
What is LNSR's EPS (earnings per share)?
LENSAR, Inc. (LNSR)'s trailing twelve month EPS is $2.82 as of 2026-06-30.
What is LNSR's ROE (return on equity)?
LENSAR, Inc. (LNSR)'s trailing twelve month Return on Equity (ROE) is -851.75% as of 2026-06-30.
What is LNSR's ROA (return on assets)?
LENSAR, Inc. (LNSR)'s trailing twelve month Return on Assets (ROA) is 49.58% as of 2026-06-30.
What is LNSR's ROIC (return on invested capital)?
LENSAR, Inc. (LNSR)'s trailing twelve month Return on Invested Capital (ROIC) is -96.63% as of 2024-09-30.
What is LNSR's EV/EBITDA?
LENSAR, Inc. (LNSR)'s trailing twelve month EV/EBITDA is -13.33x as of 2026-06-30.